当前位置:首页 - 行情中心 - 南华生物(000504) - 财务分析

南华生物

(000504)

  

流通市值:20.78亿  总市值:22.08亿
流通股本:3.11亿   总股本:3.30亿

南华生物(000504)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.05亿元,每股收益0.00元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益8459.34万元,未分配利润-50267.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产54218.77万元,负债45759.43万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入104,759,853.1470,433,702.634,739,572.68200,345,457.02
营业总成本113,192,341.1275,767,566.5535,814,358.27207,266,211.43
营业利润4,865,711.31-6,405,203.33-166,240.48-26,149,344.05
利润总额5,870,133.18-5,405,490.16832,560.52-21,559,416.43
净利润4,709,236.4-5,821,413.69437,868.11-29,761,420.25
其他综合收益----
综合收益总额4,709,236.4-5,821,413.69437,868.11-29,761,420.25
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计419,448,529.08419,313,942.3420,281,160.4416,235,973.16
非流动资产合计122,739,211.11131,343,845.57134,145,672.14136,828,754.2
资产总计542,187,740.19550,657,787.87554,426,832.54553,064,727.36
流动负债合计440,505,099.98461,289,481.87456,123,365.04455,151,664.18
非流动负债合计17,089,203.9415,305,519.8217,981,399.5218,028,863.31
负债合计457,594,303.92476,595,001.69474,104,764.56473,180,527.49
归属于母公司股东权益合计14,257,921.924,798,048.6211,795,158.5113,771,203.62
股东权益合计84,593,436.2774,062,786.1880,322,067.9879,884,199.87
负债和股东权益合计542,187,740.19550,657,787.87554,426,832.54553,064,727.36
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计155,278,948.1108,433,482.3255,798,690.84365,461,811.67
经营活动现金流出小计134,854,383.7899,215,225.3355,577,192.16199,080,568.63
经营活动产生的现金流量净额20,424,564.329,218,256.99221,498.68166,381,243.04
投资活动现金流入小计424,144,822.76314,600,713.01115,711,159.14249,315,576.06
投资活动现金流出小计411,644,318.83316,036,312.82125,569,394.37265,432,798.83
投资活动产生的现金流量净额12,500,503.93-1,435,599.81-9,858,235.23-16,117,222.77
筹资活动现金流入小计28,000,00018,000,0008,000,00075,139,444.26
筹资活动现金流出小计60,813,352.8326,423,545.5511,440,558.04160,290,126.65
筹资活动产生的现金流量净额-32,813,352.83-8,423,545.55-3,440,558.04-85,150,682.39
汇率变动对现金及现金等价物的影响100.3100.3-226.14
现金及现金等价物净增加额111,815.72-640,788.07-13,077,294.5965,113,564.02
期末现金及现金等价物余额218,230,076.45217,477,472.66205,040,966.14218,118,260.73
TOP↑